Document is current
Any future updates will be listed below
-
Authors
Martinez, M. N. https://orcid.org/0000-0002-4512-853X
Mochel, J. P. https://orcid.org/0000-0002-0997-3111
Allenspach, K. https://orcid.org/0000-0002-2168-5809
Zdyrski, C. https://orcid.org/0000-0002-7556-5298
Krishna, S. https://orcid.org/0000-0002-4960-2753
Rusyn, I. https://orcid.org/0000-0001-9340-7384
- License Information
-
More Information
Article History
Received: 12 March 2026
Accepted: 18 May 2026
First Online: 29 May 2026
Declarations
:
: The findings and conclusions in this research have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency endorsement, determination, or policy. The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the FDA.
: No animals were used in the writing of this Commentary.
: "No, but part of the graphical abstract had assist from Google AI. This was indicated in the figure.".
: Ivan Rusyn has no conflicts of interest to declare.Jonathan Mochel is a co-founder of 3D Health Solutions Inc., a small biotechnology company specializing in the development of animal-derived organoids for drug testing.Karin Allenspach co-founder of 3D Health Solutions. She serves as a consultant for Ceva Animal Health, Antech Diagnostics, hills, Royal Canin, Purina, and Heel GmbH.Christopher Zdyrski is the Director of Research and Product Development at 3D Health Solutions.Shagun Krishna has no conflicts of interest to declare.Marilyn N. Martinez has no conflicts of interest to declare.
